PIC Group, Inc

Crane Nuclear, based in Kennesaw, has been a trusted provider of valves, valve services, diagnostics, and training to the nuclear industry for over six decades, since its establishment in 1956. Specializing in serving the unique needs of the nuclear sector, Crane Nuclear offers comprehensive solutions and expertise in valve-related services, ensuring safety and efficiency in nuclear operations. Generated from their website's infomation

UCB Pharma is one of many wholly-owned subsidiaries of UCB S.A., a biopharmaceutical leader specializing in fields of central nervous system disorders, allergy and respiratory diseases, immune and inflammatory disorders and oncology. The company s main products include Keppra, Xyzal, Nootropil, Atarax, Lortab, Tussionex, Metadate CD, Equasym XL and Dipentum. The company directs profits from the sale and distribution of its products toward further research in its many fields. UCB Pharma s parent company maintains numerous additional facilities worldwide. The company recently acquired Celltech Group, helping form one of the world s largest biopharmaceutical companies. UCB was founded in 1928 by Emmanuel Janssen, a far-sighted Belgian businessman. UCB Pharma maintains its headquarters in Smyrna, Ga.

The National Tuberculosis Coalition of America (NTCA) is a leading organization that brings together the leaders of tuberculosis control programs across the United States. Established in 1995 as the National Tuberculosis Controllers Association, the NTCA has expanded its reach to include state and territorial programs, as well as county and city health departments involved in TB control activities. With a focus on collaboration and advocacy, the NTCA plays a crucial role in promoting effective strategies for the prevention and control of tuberculosis. As a trusted resource in the field, the NTCA provides a platform for knowledge sharing and professional development through various committees, workgroups, and annual meetings. The organization is committed to staying at the forefront of advancements in TB control, evidenced by its involvement in addressing emerging challenges such as TB-COVID-19 and drug and diagnostic shortages. With its recent name change to the National Tuberculosis Coalition of America, the NTCA continues to evolve and adapt to the changing landscape of tuberculosis control, ensuring the well-being of communities across the nation.Generated from the website